Karin E. Garvey

Partner

Overview

Karin E. Garvey is a Partner in the New York office of Labaton Sucharow LLP and a member of the Antitrust and Competition Litigation Practice.  With more than two decades of litigation experience, Karin focuses on representing businesses and public pension funds in complex antitrust class actions.

Karin was recently appointed lead or co-lead counsel in the following antitrust class actions:

•  Fusion Elite All Stars v. Varsity Brands, LLC (W.D. Tenn.) – alleging monopolization and conspiracy to monopolize against the largest competition producer and apparel manufacturer in the market for All Star Cheer and the sport’s allegedly independent oversight body.
•  In re Humira (Adalimumab) Antitrust Litigation (N.D. Ill.) – alleging that a brand drugmaker colluded with a group of global rivals to divide the market for the blockbuster drug Humira between the U.S. and Europe and that it used a “patent thicket” to illegally maintain its monopoly.
•  In re Sensipar (Cinacalcet HCl) Antitrust Litigation (D. Del.) – alleging that a brand and a generic drug company entered into an anticompetitive agreement to eliminate competition for sales of Sensipar.
•  In re Surescripts Antitrust Litigation (N.D. Ill.) – alleging that health information technology company Surescripts, which provides e-prescription routing and eligibility services, monopolized the market for e-prescription services and, along with two other defendants, conspired to monopolize the market.
 

Karin was also appointed to the Plaintiff's Steering Committee in In re Xyrem (Sodium Oxybate) Antitrust Litigation (N.D. Cal.) a class action alleging, inter alia, that a brand drugmaker entered into anticompetitive pay-for-delay agreements with generic competitors and In re Crop Inputs Antitrust Litigation (E.D. Mo.) a class action alleging, inter alia, that major manufacturers of crop inputs (e.g., seeds and pesticides) conspired to suppress competition and to fix prices.

Karin is recommended by Chambers & Partners USA and The Legal 500 for excellence in the antitrust practice.  She has also been recognized by Lawdragon as one of the "Leading Plaintiff Financial Lawyers in America."

Karin brings significant experience to managing complex, multi-jurisdictional cases from initial case development through resolution and appeal.  In addition to deposing top executives, Karin has also prepared and defended company executives for deposition, hearing, and trial.  Karin has significant experience working with experts—including economists, regulatory experts, patent experts, medical experts, toxicologists, materials scientists, valuation experts, foreign law experts, and appraisers—developing reports and testimony, preparing for and defending depositions, as well as taking depositions of opponents’ experts.  In addition, Karin has engaged in all phases of trial preparation and trial and has briefed and argued appeals.  Karin also has significant experience with arbitration and mediation.

Prior to joining Labaton Sucharow, Karin practiced antitrust and general litigation at Arnold & Porter (then Kaye Scholer LLP), representing and counseling clients from a wide spectrum of industries including pharmaceuticals, cosmetics, building materials, film, finance, and private equity.

Karin is an Antitrust Section Member of the American Bar Association.

Karin obtained her Juris Doctor, cum laude, from Northwestern University School of Law, where she was a Note and Comment Editor for the Journal of Criminal Law and Criminology.  She earned her bachelor’s degree, cum laude, from Harvard University.

Admissions

1999, New York

U.S. Court of Appeals
2006, Ninth Circuit

U.S. District Courts
2000, Southern District of New York
2001, Eastern District of New York